research reports and media, page-3112

What is also interesting is they underlying insurers of these employee benefit plans (US private health insurance) are bulking at this now due to the escalating costs per patent. Humira is covered by most insurance plans, but individual plans may vary in how much they cover. Insurance may be able to lower the out-of-pocket price of Humira from about $7,389 to approximately $5,000 per month.

What these means is the Humira is not as widely administered as would have otherwise been if more accessible priced given it costs ~$84k pa long term ($60K which is out of pocket expenses for US citizens).

I recall with some admiration at the time an old interview with Dr Bloom who stated he was keen to see a proven safe and effective OA drug made accessible to everyone who needed it.